CRO

The Australia & New Zealand Site Solutions Summit is dedicated to addressing industry challenges and sharing ideas for progress, operational excellence and study growth. As the fastest growing member region for SCRS, you do not want to miss this exceptional meeting!

Advance your innovative biologics pipeline and elevate your engineering, targets and machine learning strategies – accelerating your path to the clinic and beyond.

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies — from discovery to market, with an emphasis on the European region. Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development. Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

The TIDES USA program features concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing. Your registration provides access to the presentations across all 4 tracks, allowing you to create your own customized agenda. Each year, TIDES’ scientific agenda includes 150+ of the industry’s top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products. 

The American Society for Clinical Pathology (ASCP) is the world’s largest professional membership organization for pathologists and laboratory professionals. With more than 100,000 members, the society’s influence has guided the application and evolution of the pathology and laboratory medicine specialty since 1922. The pre-eminent event for the entire laboratory team, the ASCP Annual Meeting is known for bringing together pathologists, laboratory professionals, pathology residents, and more, in a learning-focused setting you can only find once per year.

The annual meeting brings together more than 40,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies and ongoing controversies in the field.

SCDM is organized exclusively for educational and scientific purposes. Through collaborations and partnerships with other professional organizations, The Society for Clinical Data Management creates a network of professionals driving the industry forward on multiple fronts: technological, regulatory, procedural and personnel. Educational offerings, available both in-person and on-line, seek to provide the fundamental training for clinical data management skills.

Combining FDA, Notified Body and Industry Perspectives to Shape the Future of Medical Device Regulations

INTERPHEX, the leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference. INTERPHEX offers an expansive exhibition floor showcasing cutting-edge products and services from industry leaders. Attendees and exhibitors engage in enlightening seminars led by experts, delve into technology showcases spotlighting the latest innovations, and benefit from unparalleled networking opportunities. This dynamic platform unites professionals, fostering collaborations and providing a comprehensive view of advancements in pharmaceutical manufacturing, process development, and regulatory compliance. Elevate your industry knowledge, connect with key stakeholders, and stay at the forefront of pharmaceutical innovation at INTERPHEX.

With our core focus on cell and gene therapy translation, the ISCT Annual Meeting takes an integrative approach across ALL stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialization and ultimately patient access.  Topics are curated to addresses the biggest bottlenecks in cell and gene therapy development.